127 related articles for article (PubMed ID: 38859834)
1. Cancer-associated MDM2 W329G mutant attenuates ribosomal stress-mediated p53 responses to promote cell survival and glycolysis.
Lien S; Whitbread TP; Shastri SO; Contreras JA; Zhao R; Zhu Y
Am J Cancer Res; 2024; 14(5):2141-2156. PubMed ID: 38859834
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
3. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
4. Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.
Zhang Q; Xiao H; Chai SC; Hoang QQ; Lu H
J Biol Chem; 2011 Nov; 286(44):38264-38274. PubMed ID: 21903592
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.
Dai MS; Lu H
J Biol Chem; 2004 Oct; 279(43):44475-82. PubMed ID: 15308643
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.
Zhou X; Hao Q; Liao J; Zhang Q; Lu H
Oncogene; 2013 Jan; 32(3):388-96. PubMed ID: 22391559
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
[TBL] [Abstract][Full Text] [Related]
9. Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
Kamio T; Gu BW; Olson TS; Zhang Y; Mason PJ; Bessler M
PLoS One; 2016; 11(4):e0152263. PubMed ID: 27042854
[TBL] [Abstract][Full Text] [Related]
10. Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.
Sun XX; Wang YG; Xirodimas DP; Dai MS
J Biol Chem; 2010 Aug; 285(33):25812-21. PubMed ID: 20554519
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop.
He X; Li Y; Dai MS; Sun XX
Oncotarget; 2016 Mar; 7(13):16217-26. PubMed ID: 26908445
[TBL] [Abstract][Full Text] [Related]
12. Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.
Cao B; Fang Z; Liao P; Zhou X; Xiong J; Zeng S; Lu H
Oncotarget; 2017 Oct; 8(53):90651-90661. PubMed ID: 29207594
[TBL] [Abstract][Full Text] [Related]
13. The RP-Mdm2-p53 pathway and tumorigenesis.
Miliani de Marval PL; Zhang Y
Oncotarget; 2011 Mar; 2(3):234-8. PubMed ID: 21406728
[TBL] [Abstract][Full Text] [Related]
14. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner.
Mahata B; Sundqvist A; Xirodimas DP
Oncogene; 2012 Jun; 31(25):3060-71. PubMed ID: 22081073
[TBL] [Abstract][Full Text] [Related]
16. Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation.
Zheng J; Lang Y; Zhang Q; Cui D; Sun H; Jiang L; Chen Z; Zhang R; Gao Y; Tian W; Wu W; Tang J; Chen Z
Genes Dev; 2015 Jul; 29(14):1524-34. PubMed ID: 26220995
[TBL] [Abstract][Full Text] [Related]
17. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
Dai MS; Shi D; Jin Y; Sun XX; Zhang Y; Grossman SR; Lu H
J Biol Chem; 2006 Aug; 281(34):24304-13. PubMed ID: 16803902
[TBL] [Abstract][Full Text] [Related]
19. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.
Goudarzi KM; Nistér M; Lindström MS
Cancer Biol Ther; 2014; 15(11):1499-514. PubMed ID: 25482947
[TBL] [Abstract][Full Text] [Related]
20. Direct and indirect roles of GRWD1 in the inactivation of p53 in cancer.
Ichikawa MK; Saitoh M
J Biochem; 2022 May; 171(6):601-603. PubMed ID: 35171268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
